SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Onur Boyman, Denis Comte, François Spertini, Adverse reactions to biologic agents and their medical management, Nature Reviews Rheumatology, 2014, 10, 10, 612

    CrossRef

  2. 2
    A. Rubbert-Roth, G.R. Burmester, T. Dörner, A. Gause, Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2014, 73, 2, 165

    CrossRef

  3. 3
    Boleslaw Lach, Barbara Connolly, Christian Wüthrich, Igor J. Koralnik, Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis, Neuropathology, 2014, 34, 1
  4. 4
    José M. Ferro, Sofia N. Oliveira, Luis Correia, Neurologic Aspects of Systemic Disease Part II, 2014,

    CrossRef

  5. 5
    Jean G. Sathish, Swaminathan Sethu, Marie-Christine Bielsky, Lolke de Haan, Neil S. French, Karthik Govindappa, James Green, Christopher E. M. Griffiths, Stephen Holgate, David Jones, Ian Kimber, Jonathan Moggs, Dean J. Naisbitt, Munir Pirmohamed, Gabriele Reichmann, Jennifer Sims, Meena Subramanyam, Marque D. Todd, Jan Willem Van Der Laan, Richard J. Weaver, B. Kevin Park, Challenges and approaches for the development of safer immunomodulatory biologics, Nature Reviews Drug Discovery, 2013, 12, 4, 306

    CrossRef

  6. 6
    Anna Bellizzi, Elena Anzivino, Donatella Rodio, Sara Cioccolo, Rossana Scrivo, Manuela Morreale, Simona Pontecorvo, Federica Ferrari, Giovanni Di Nardo, Lucia Nencioni, Silvia Carluccio, Guido Valesini, Ada Francia, Salvatore Cucchiara, Anna Palamara, Valeria Pietropaolo, Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study, Virology Journal, 2013, 10, 1, 298

    CrossRef

  7. 7
    Cillian F. De Gascun, Michael J. Carr, Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  8. 8
    Manola Comar, Serena Delbue, Loredana Lepore, Stefano Martelossi, Oriano Radillo, Luca Ronfani, Pierlanfranco D'Agaro, Pasquale Ferrante, Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2, Journal of Medical Virology, 2013, 85, 4
  9. 9
    Anna Bellizzi, Elena Anzivino, Donatella Maria Rodio, Anna Teresa Palamara, Lucia Nencioni, Valeria Pietropaolo, New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  10. 10
    A. Rubbert-Roth, Assessing the safety of biologic agents in patients with rheumatoid arthritis, Rheumatology, 2012, 51, suppl 5, v38

    CrossRef

  11. 11
    Simone Giannecchini, Valeria Clausi, Alessandra Vultaggio, Lisa Macera, Fabrizio Maggi, Francesco Martelli, Alberta Azzi, Enrico Maggi, Andrea Matucci, Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab, Journal of NeuroVirology, 2012, 18, 1, 55

    CrossRef

  12. 12
    Cesar Ramos-Remus, Sergio Duran-Barragan, Jose Dionisio Castillo-Ortiz, Beyond the joints, Clinical Rheumatology, 2012, 31, 1, 1

    CrossRef

  13. You have free access to this content13
    ID O’Neill, C Scully, Biologics in oral medicine: principles of use and practical considerations, Oral Diseases, 2012, 18, 6
  14. 14
    A. Bellizzi, C. Nardis, E. Anzivino, D. M. Rodìo, D. Fioriti, M. Mischitelli, F. Chiarini, V. Pietropaolo, Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies, Journal of NeuroVirology, 2012, 18, 1, 1

    CrossRef

  15. 15
    A. Bharat, F. Xie, J. W. Baddley, T. Beukelman, L. Chen, L. Calabrese, E. Delzell, C. G. Grijalva, N. M. Patkar, K. Saag, K. L. Winthrop, J. R. Curtis, Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic diseases, Arthritis Care & Research, 2012, 64, 4
  16. 16
    Elisabeth Palazzo, Salim Ahmed Yahia, Leucoencéphalite multiple progressive dans les maladies auto-immunes, Revue du Rhumatisme, 2012, 79, 3, 201

    CrossRef

  17. 17
    Julianne Bayliss, Catherine L Cherry, Catriona A McLean, Plasma levels of JC virus are sensitive and specific for detecting and predicting progressive multifocal leukoencephalopathy in HIV patients, Future Virology, 2012, 7, 8, 833

    CrossRef

  18. 18
    Eamonn S. Molloy, Leonard H. Calabrese, Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies, Arthritis & Rheumatism, 2012, 64, 9
  19. 19
    Jonathan Graff-Radford, Maisha T. Robinson, Rahma M. Warsame, Eric L. Matteson, Scott D. Z. Eggers, B. Mark Keegan, Progressive Multifocal Leukoencephalopathy in a Patient Treated With Etanercept, The Neurologist, 2012, 18, 2, 85

    CrossRef

  20. 20
    Nina D. Wagner-Johnston, Nancy L. Bartlett, Amanda Cashen, Joseph R. Berger, Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin, Leukemia & Lymphoma, 2012, 53, 11, 2283

    CrossRef

  21. 21
    Elisabeth Palazzo, Salim Ahmed Yahia, Progressive multifocal leukoencephalopathy in autoimmune diseases, Joint Bone Spine, 2012, 79, 4, 351

    CrossRef

  22. 22
    D. Spoerl, Andreas J. Bircher, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2012,

    CrossRef

  23. 23
    Despina Moshous, Isabelle Meyts, Sylvie Fraitag, Carl E.I. Janssen, Marianne Debré, Felipe Suarez, Jaan Toelen, Kris De Boeck, Tania Roskams, Antoine Deschildre, Capucine Picard, Christine Bodemer, Carine Wouters, Alain Fischer, Granulomatous inflammation in cartilage-hair hypoplasia: Risks and benefits of anti–TNF-α mAbs, Journal of Allergy and Clinical Immunology, 2011, 128, 4, 847

    CrossRef

  24. 24
    Mary L. Stevenson, Mark Lebwohl, Iatrogenic effects of biologics for psoriasis, Clinics in Dermatology, 2011, 29, 6, 614

    CrossRef

  25. 25
    Andrea T. Borchers, Naama Leibushor, Gurtej S. Cheema, Stanley M. Naguwa, M. Eric Gershwin, Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases, Journal of Autoimmunity, 2011, 37, 4, 273

    CrossRef

  26. 26
    Anna Bellizzi, Elena Anzivino, Federica Ferrari, Giovanni Di Nardo, Maria Teresa Colosimo, Daniela Fioriti, Monica Mischitelli, Fernanda Chiarini, Salvatore Cucchiara, Valeria Pietropaolo, Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab, Journal of NeuroVirology, 2011, 17, 4, 303

    CrossRef

  27. 27
    D. Meyer-Olson, K. Hoeper, R.E. Schmidt, Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2010, 69, 10, 879

    CrossRef